IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis

Journal of Immunology

Volumn 167, Issue 2, 2001, Pages 1004-1013

  Lubberts, E ^a   Joosten, L A B ^a   Oppers, B ^a   Van den Bersselaar, L ^a   Coenen De Roo, C J J ^a   Kolls, J K ^a   Schwarzenberger, P ^a   Van de Loo, F A J ^a   Van den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERLEUKIN 1; INTERLEUKIN 17;

ALLOGRAFT; ANIMAL CELL; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; DRUG INDUCED DISEASE; GRAFT REJECTION; JOINT DEGENERATION; MEMORY CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; SYNOVITIS; T LYMPHOCYTE ACTIVATION;

EID: 0035879192     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.2.1004     Document Type: Article

References (45)

1. T-cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
2. Human IL-17: A novel cytokine derived from T cells
3. Herpesvirus saimiri encodes a new cytokine IL-17, which binds to a novel cytokine receptor
4. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells
5. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages
6. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin-17 signal transduction
7. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors
8. Neutrophil recruitment by human IL- 17 via C-X-C chemokine release in the airways
9. IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines
10. The pathophysiology and treatment of rheumatoid arthritis
11. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
12. Enhancing effect of IL-17 on 1L-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines
13. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4
14. Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: Possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK)
15. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
16. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
17. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Ra
18. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis
19. Dual role of IL-12 in early and late stages of murine collagen type II arthritis
20. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
21. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology
22. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-I7 production via cyclosporin A-sensitive mechanism
23. Resistance to fever induction and impaired acute-phase response in IL-1β-deficient mice
24. Role of interleukin-1 (IL-I), tumor necrosis factor α (TNFα), and interleukin-6 (IL-6) in cartilage proteoglycan metabolism and destruction: Effect of in situ blocking in murine antigen- and zymosan-induced arthritis
25. Intraarticular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw
26. Adenoviral vector-mediated over-expression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction
27. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
28. Endurance run increases circulating IL-6 and IL-1Ra but downregulates ex vivo TNFα and IL-1β production
29. Quantification of mRNA levels in joint capsule and articular cartilage of murine knee joint by RT-PCR. Rheumatol
30. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
31. Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice
32. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein
33. Amelioration of established murine collagen-induced arthritis with anti-1L-1 treatment
34. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor I in rheumatoid arthritis
35. Th1/Th2 cytokine balance in arthritis
36. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
37. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-I production in rheumatoid arthritis
38. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis
39. Effect of interleukin-17 on proteoglycan degradation in murine knee joints
40. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by 1L-17 in airways in vivo
41. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: Escape from inactivation by I-1-proteinase inhibitor
42. Elastase and cathepsin G of human monocytes: Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity
43. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
44. Interleukin-17: A new bone acting cytokine in vitro
45. Tumor necrosis factor I stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction